Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 1 paper. Top paper: “A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease”.
T. C. Nichols, H. L. CHAPMAN, R. C. JANKOWITZ, A. M. Dillow, E. P. Merricks +2 more